These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5635434)

  • 21. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 22. Liver function, age, and portasystemic encephalopathy.
    Kardel T
    Neth J Med; 1974; 17(2):50-3. PubMed ID: 4839374
    [No Abstract]   [Full Text] [Related]  

  • 23. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 26. Precipitating factors in genesis of hepatic coma.
    Faloon WW; Evans GL
    N Y State J Med; 1970 Dec; 70(23):2891-6. PubMed ID: 5312239
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental hepatic coma caused by acute ischemic necrosis of the liver in pigs. Attempted prevention and treatment with cross hemodialysis].
    Opolon P; Huguet C; Hadchouel P; Morisot P; Bloch P; Gallot D; Duhurt J; Connard J; Sausse A; Stern A; Granger A; Caroli J
    Ann Med Interne (Paris); 1971; 122(8):819-32. PubMed ID: 5124358
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition by acetohydroxamic acid of human mucosal and faecal urease-specific activity.
    Aoyagi T; Summerskill WH
    Lancet; 1966 Feb; 1(7432):296-7. PubMed ID: 4158898
    [No Abstract]   [Full Text] [Related]  

  • 30. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
    Bircher J; Haemmerli UP; Williams R
    Gastroenterology; 1970 Apr; 58(4):595-7. PubMed ID: 5438009
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats].
    Bircher J; Gmünder U; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Strahlentherapie Sonderb; 1968; 67():330-6. PubMed ID: 5719130
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 33. Tyrosine metabolism in patients with liver disease.
    Levine RJ; Conn HO
    J Clin Invest; 1967 Dec; 46(12):2012-20. PubMed ID: 6074004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrahepatic portal arterialization associated with portacaval shunt: a preliminary experimental report].
    Dong FZ
    Zhonghua Wai Ke Za Zhi; 1983 Apr; 21(4):211-6. PubMed ID: 6617376
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anabolic steroids and liver diseases].
    Wewalka F
    Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
    Fodor O; Popescu S; Grigoraş D; Barbarino F
    Med Interna (Bucur); 1968 Jul; 20(7):781-5. PubMed ID: 5685308
    [No Abstract]   [Full Text] [Related]  

  • 37. [Corticosteroid therapy in hepatic diseases].
    Mazzacca G
    Recenti Prog Med; 1967 Jul; 43(1):51-70. PubMed ID: 4302862
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ammonia intoxication in cirrhotics].
    Doxiades T; Baraloudis P; Sorokiadou D
    Cah Anesthesiol; 1968 Mar; 16(2):171-9. PubMed ID: 5744226
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of acetohydroxamic acid on rumen urease activity in vitro.
    Makkar HP; Sharma OP; Dawra RK; Negi SS
    J Dairy Sci; 1981 Apr; 64(4):643-8. PubMed ID: 7264024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arginase and experimental hyperammoniemia. II. Action of arginase on experimental portacaval encephalopathy in the dog].
    AIMARD G; MAILLET P; VILLAROS J; DUFFRENE D
    Presse Med (1893); 1962 May; 70():1204-6. PubMed ID: 13859792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.